Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up

Autor:	S. Kusamura, V. Kepenekian, L. Villeneuve, R.J. Lurvink, K. Govaerts, I.H.J.T. De Hingh, B.J. Moran, K. Van der Speeten, M. Deraco, O. Glehen, Pedro Barrios-Sanchez, Joel M. Baumgartner, Almog Ben-Yaacov, Rosella Bertulli, Peter Cashin, Tom Cecil, Sanjeev Dayal, Michele De Simone, Jason M. Foster, Diane Goere, Kuno Lehmann, Yan Li, Brian W. Loggie, Faheez Mohamed, David L. Morris, Aviram Nissan, Pompiliu Piso, Marc Pocard, Beate Rau, Marc A. Reymond, Lucas Sideris, John D. Spiliotis, Paul H. Sugarbaker, Victor J. Verwaal, Malcom S. Wilson, Yutaka Yonemura, Yang Yu
Rok vydání:	2021
Předmět:	Diagnostic Imaging Mesothelioma medicine.medical_specialty Delphi Technique Peritoneal surface Steering committee Hyperthermic Intraperitoneal Chemotherapy Peritoneal malignancy 03 medical and health sciences 0302 clinical medicine Humans Medicine Peritoneal Neoplasms business.industry Cytoreduction Surgical Procedures General Medicine medicine.disease respiratory tract diseases Clinical Practice Oncology Diagnosis treatment Malignant Peritoneal Mesothelioma 030220 oncology & carcinogenesis Peritoneal mesothelioma 030211 gastroenterology & hepatology Surgery Hyperthermic intraperitoneal chemotherapy Radiology business
Zdroj:	European Journal of Surgical Oncology. 47:36-59
ISSN:	0748-7983
DOI:	10.1016/j.ejso.2020.02.011
Popis:	Peritoneal mesothelioma (PM) is a rare and aggressive primary peritoneal malignancy characterized by widespread multiple metastatic tumour nodules originating from the peritoneum. The conventional classification distinguishes diffuse malignant peritoneal mesothelioma (DMPM) and border-line forms: multicystic peritoneal mesothelioma (MCPM) and well-differentiated papillary peritoneal mesothelioma (WDPPM). Despite the novel achievements in the management of PM, there is difficulty in conducting randomized trials due to its rarity and aggressive biology in many cases. As there is, a necessity to standardize diagnosis and management of PM, the Peritoneal Surface Oncology Group International (PSOGI) commissioned a steering committee to elaborate clinical guidelines.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0230a547862ee4fbdc9ce4fe2c1960 https://doi.org/10.1016/j.ejso.2020.02.011 Zobrazit plný text záznamu Full Text from ScienceDirect